Skip to main content
Erschienen in: World Journal of Surgery 6/2007

01.06.2007

Beneficial Effect of Partial Portal Decompression Using the Inferior Mesenteric Vein for Intractable Gastroesophageal Variceal Bleeding in Patients With Liver Cirrhosis

verfasst von: Satoshi Yamamoto, Yoshinobu Sato, Hideki Nakatsuka, Hiroshi Oya, Takashi Kobayashi, Katsuyoshi Hatakeyama

Erschienen in: World Journal of Surgery | Ausgabe 6/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

Use of the inferior mesenteric vein (IMV) for partial portal decompression has not been recommended as a first-line option for intractable gastroesophageal variceal bleeding because of the thin diameter of the vein. Although these indications remain relevant, few reports have compared partial portal decompression using the IMV with other therapies. We propose that partial portal decompression using the IMV is a useful alternative treatment for intractable variceal bleeding.

Methods

We performed partial portal decompression using the IMV in eight patients with intractable variceal bleeding that had been uncontrolled using medical and endoscopic therapies. All patients were classified into Child’s class B or C. The surgical data, morbidity, and mortality were assessed.

Results

Mean portal venous pressure significantly decreased from 26.9 ± 2.0 mmHg before the surgery to 19.8 ± 3.9 mmHg after the surgery. The operative mortality rate was 0%. The mean duration of hospital stay was 25.5 ± 13.3 days. Although one patient experienced recurrent bleeding, shunt patency was well maintained in all patients during the follow-up period (mean 28.9 ± 14.1 months). Six patients are still alive and well without ascites or hepatic encephalopathy. Two of the Child’s class C patients who underwent emergency shunt died owing to hepatic decompensation.

Conclusion

Partial portal decompression using the IMV can be a safe, effective way to treat intractable variceal bleeding in patients with liver cirrhosis. However, use of the shunt procedure may have the most survival benefits for cirrhotic patients with preserved liver function.
Literatur
1.
Zurück zum Zitat Macdougall BR, Westaby D, Theodossi A, et al. (1982) Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Lancet 1:124–127PubMedCrossRef Macdougall BR, Westaby D, Theodossi A, et al. (1982) Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Lancet 1:124–127PubMedCrossRef
2.
Zurück zum Zitat Infante-Rivard C, Esnaola S, Villeneuve JP (1989) Role of endoscopic variceal sclerotherapy in the long-term management of variceal bleeding: a met-aanalysis. Gastroenterology 96:1087–1092PubMed Infante-Rivard C, Esnaola S, Villeneuve JP (1989) Role of endoscopic variceal sclerotherapy in the long-term management of variceal bleeding: a met-aanalysis. Gastroenterology 96:1087–1092PubMed
3.
Zurück zum Zitat Westaby D, Hayes PC, Gimson AE, et al. (1989) Controlled clinical trial of injection sclerotherapy for active variceal bleeding. Hepatology 9:274–277PubMedCrossRef Westaby D, Hayes PC, Gimson AE, et al. (1989) Controlled clinical trial of injection sclerotherapy for active variceal bleeding. Hepatology 9:274–277PubMedCrossRef
4.
Zurück zum Zitat LaBerge JM, Ring EJ, Gordon RL, et al. (1993) Creation of transjugular intrahepatic portosystemic shunts with the Wallstent endoprosthesis: results in 100 patients. Radiology 187:413–420PubMed LaBerge JM, Ring EJ, Gordon RL, et al. (1993) Creation of transjugular intrahepatic portosystemic shunts with the Wallstent endoprosthesis: results in 100 patients. Radiology 187:413–420PubMed
5.
Zurück zum Zitat Rossle M, Haag K, Ochs A, et al. (1994) The transjuglar intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 330:165–171PubMedCrossRef Rossle M, Haag K, Ochs A, et al. (1994) The transjuglar intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 330:165–171PubMedCrossRef
6.
Zurück zum Zitat Langer BF, Greig PD, Taylor BR (1990) Emergency surgical treatment of variceal hemorrhage. Surg Clin North Am 70:307–317PubMed Langer BF, Greig PD, Taylor BR (1990) Emergency surgical treatment of variceal hemorrhage. Surg Clin North Am 70:307–317PubMed
7.
Zurück zum Zitat Rikkerrs LF, Jin G (1994) Surgical management of acute variceal hemorrage. World J Surg 18:193–199CrossRef Rikkerrs LF, Jin G (1994) Surgical management of acute variceal hemorrage. World J Surg 18:193–199CrossRef
8.
Zurück zum Zitat Rikkerrs LF, Jin G (1995) Emergency shunt: role in the present management of variceal bleeding. Arch Surg 130:472–477 Rikkerrs LF, Jin G (1995) Emergency shunt: role in the present management of variceal bleeding. Arch Surg 130:472–477
9.
Zurück zum Zitat Orloff MJ, Orloff MS, Rambotti M, et al. (1992) Is portal-systemic shunt worthwhile in Child’s class C cirrhosis? Long-term results of emergency shunt in 94 patients with bleeding varices. Ann Surg 216:256–268PubMedCrossRef Orloff MJ, Orloff MS, Rambotti M, et al. (1992) Is portal-systemic shunt worthwhile in Child’s class C cirrhosis? Long-term results of emergency shunt in 94 patients with bleeding varices. Ann Surg 216:256–268PubMedCrossRef
10.
Zurück zum Zitat Nagasue N, Kohno H, Ogawa Y, et al. (1989) Appraisal of distal splenorenal shunt in the treatment of esophageal varices: an analysis of prophylactic, emergency, and elective shunts. World J Surg 13:92–99PubMedCrossRef Nagasue N, Kohno H, Ogawa Y, et al. (1989) Appraisal of distal splenorenal shunt in the treatment of esophageal varices: an analysis of prophylactic, emergency, and elective shunts. World J Surg 13:92–99PubMedCrossRef
11.
Zurück zum Zitat Deshmukh N, Ayerdi J, Roldan RC (1999) Surgical technique for inferior mesenteric vein to renal vein shunt in portal hypertension. Am J Surg 178:55–56PubMedCrossRef Deshmukh N, Ayerdi J, Roldan RC (1999) Surgical technique for inferior mesenteric vein to renal vein shunt in portal hypertension. Am J Surg 178:55–56PubMedCrossRef
12.
Zurück zum Zitat Yamamoto S, Sato Y, Hatakeyama K (2004) Partial portal decompression using inferior mesenteric vein in portal hypertension. Am J Surg 187:567–568PubMedCrossRef Yamamoto S, Sato Y, Hatakeyama K (2004) Partial portal decompression using inferior mesenteric vein in portal hypertension. Am J Surg 187:567–568PubMedCrossRef
13.
Zurück zum Zitat Beppu K, Inokuchi K, Koyanagi N, et al. (1981) Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 27:213–218PubMed Beppu K, Inokuchi K, Koyanagi N, et al. (1981) Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 27:213–218PubMed
14.
Zurück zum Zitat Kanaya S, Katoh H (1995) Long-term evaluation of distal splenorenal shunt with splenopancreatic and gastric disconnection. Surgery 118:29–35PubMedCrossRef Kanaya S, Katoh H (1995) Long-term evaluation of distal splenorenal shunt with splenopancreatic and gastric disconnection. Surgery 118:29–35PubMedCrossRef
15.
Zurück zum Zitat Spina GP, Henderson JM, Rikker LF, et al. (1992) Distal splenorenal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding: a meta-analysis of 4 randomized clinical trials. J Hepatol 16:338–345PubMedCrossRef Spina GP, Henderson JM, Rikker LF, et al. (1992) Distal splenorenal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding: a meta-analysis of 4 randomized clinical trials. J Hepatol 16:338–345PubMedCrossRef
16.
Zurück zum Zitat Sato Y, Hatakeyama K (2002) Left gastric venous caval direct shunt in esophagogastric varices. Hepatogastroenterology 49:1251–1252PubMed Sato Y, Hatakeyama K (2002) Left gastric venous caval direct shunt in esophagogastric varices. Hepatogastroenterology 49:1251–1252PubMed
17.
Zurück zum Zitat Yamamoto S, Sato Y, Takeishi T, et al. (2005) Successful surgical treatment for hepatocellular carcinoma and concomitant risky esophageal varices. Hepatogastroenterology 52:1083–1086PubMed Yamamoto S, Sato Y, Takeishi T, et al. (2005) Successful surgical treatment for hepatocellular carcinoma and concomitant risky esophageal varices. Hepatogastroenterology 52:1083–1086PubMed
18.
Zurück zum Zitat Hidajat N, Vogl T, Stobbe H, et al. (2000) Transjuglar intrahepatic portosystemic shunt: experiences at a liver transplant center. Acta Radiol 41:474–478PubMedCrossRef Hidajat N, Vogl T, Stobbe H, et al. (2000) Transjuglar intrahepatic portosystemic shunt: experiences at a liver transplant center. Acta Radiol 41:474–478PubMedCrossRef
19.
Zurück zum Zitat Rosemurgy AS, Bloomston M, Clark WC, et al. (2005) H-graft portacaval shunts versus TIPS: ten-year follow-up of a randomized trial with comparison to predicted survivals. Ann Surg 241:238–246PubMedCrossRef Rosemurgy AS, Bloomston M, Clark WC, et al. (2005) H-graft portacaval shunts versus TIPS: ten-year follow-up of a randomized trial with comparison to predicted survivals. Ann Surg 241:238–246PubMedCrossRef
20.
Zurück zum Zitat Henderson JM, Nagle A, Curtas S, et al. (2000) Surgical shunts and TIPS for variceal decompression in 1990’s. Surgery 128:540–547PubMedCrossRef Henderson JM, Nagle A, Curtas S, et al. (2000) Surgical shunts and TIPS for variceal decompression in 1990’s. Surgery 128:540–547PubMedCrossRef
21.
Zurück zum Zitat Chui AK, Rao AR, Waugh RC, et al. (2000) Liver transplantation in patients with transjuglar intrahepatic portosystemic shunts. Aust N Z J Surg 70:493–495PubMedCrossRef Chui AK, Rao AR, Waugh RC, et al. (2000) Liver transplantation in patients with transjuglar intrahepatic portosystemic shunts. Aust N Z J Surg 70:493–495PubMedCrossRef
22.
Zurück zum Zitat Luca A, D’Amino G, La Galla R, et al. (1999) TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology 212:411–421PubMed Luca A, D’Amino G, La Galla R, et al. (1999) TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology 212:411–421PubMed
23.
Zurück zum Zitat Drews JA, Castagna J (1976) Inferior mesorenal shunt as a second procedure for portal decompression. Surg Gynecol Obstet 142:84–86PubMed Drews JA, Castagna J (1976) Inferior mesorenal shunt as a second procedure for portal decompression. Surg Gynecol Obstet 142:84–86PubMed
24.
Zurück zum Zitat Warren WD, Millikan WJ Jr, Henderson JM, et al. (1984) Selective variceal decompression after splenectomy or splenic vein thorombosis: with a note on splenopancreatic disconnection. Ann Surg 199:696–702CrossRef Warren WD, Millikan WJ Jr, Henderson JM, et al. (1984) Selective variceal decompression after splenectomy or splenic vein thorombosis: with a note on splenopancreatic disconnection. Ann Surg 199:696–702CrossRef
25.
Zurück zum Zitat Gorini P, Johansen K (1998) Portal decompression using the inferior mesenteric vein. HPB Surg 10:365–370PubMed Gorini P, Johansen K (1998) Portal decompression using the inferior mesenteric vein. HPB Surg 10:365–370PubMed
26.
Zurück zum Zitat Sarfeh J, Rypins EB, Mason GR (1986) A systematic appraisal of portacaval H-graft diameters. Ann Surg 204:356–363PubMedCrossRef Sarfeh J, Rypins EB, Mason GR (1986) A systematic appraisal of portacaval H-graft diameters. Ann Surg 204:356–363PubMedCrossRef
27.
Zurück zum Zitat Hillebrand DJ, Kojouri K, Cao S, et al. (2000) Small-diameter portocaval H-graft shunt: a paradigm shift back to surgical shunting in the management of variceal bleeding in patients with preserved liver function. Liver Transpl 6:459–465PubMedCrossRef Hillebrand DJ, Kojouri K, Cao S, et al. (2000) Small-diameter portocaval H-graft shunt: a paradigm shift back to surgical shunting in the management of variceal bleeding in patients with preserved liver function. Liver Transpl 6:459–465PubMedCrossRef
28.
Zurück zum Zitat Azoulay D, Castaing D, Majno P, et al. (2001) Salvage transjuglar intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol 35:590–597PubMedCrossRef Azoulay D, Castaing D, Majno P, et al. (2001) Salvage transjuglar intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol 35:590–597PubMedCrossRef
29.
Zurück zum Zitat Rosemurgy AS, McAllister EW, Kearney RE (1991) Prospective study of a prothetic H-graft portacaval shunt. Am J Surg 161:159–164PubMedCrossRef Rosemurgy AS, McAllister EW, Kearney RE (1991) Prospective study of a prothetic H-graft portacaval shunt. Am J Surg 161:159–164PubMedCrossRef
30.
Zurück zum Zitat Barton RE, Rosch J, Saxon RR, et al. (1995) TIPS: short and long-term results: a survey of 1750 patients. Semin Interv Radiol 12:364–371CrossRef Barton RE, Rosch J, Saxon RR, et al. (1995) TIPS: short and long-term results: a survey of 1750 patients. Semin Interv Radiol 12:364–371CrossRef
31.
Zurück zum Zitat Henderson JM, Boyer TD, Kutner MH, et al. (2006) Distal splenorenal shunt versus transjuglar intrahepatic portal systemic shunt for variceal bleeding: a randomized trial. Gastroenterology 130:1643–1651PubMedCrossRef Henderson JM, Boyer TD, Kutner MH, et al. (2006) Distal splenorenal shunt versus transjuglar intrahepatic portal systemic shunt for variceal bleeding: a randomized trial. Gastroenterology 130:1643–1651PubMedCrossRef
32.
Zurück zum Zitat Johansen K, Girod C, Lee SS, et al. (1990) Mesenteric venous stenosis reduces hyperammonemia in the portacaval-shunted rat. Eur Surg Res 22:170–174PubMed Johansen K, Girod C, Lee SS, et al. (1990) Mesenteric venous stenosis reduces hyperammonemia in the portacaval-shunted rat. Eur Surg Res 22:170–174PubMed
33.
Zurück zum Zitat Johansen K (1992) Prospective comparison of partial venous total portal decompression for bleeding esophageal varices. Surg Gynecol Obstet 175:528–534PubMed Johansen K (1992) Prospective comparison of partial venous total portal decompression for bleeding esophageal varices. Surg Gynecol Obstet 175:528–534PubMed
34.
Zurück zum Zitat Rosemurgy AS 2nd, Goode SE, Campas M (1996) The effect of small-diameter H-graft portocaval shunts on portal blood flow. Am J Surg 171:154–156PubMedCrossRef Rosemurgy AS 2nd, Goode SE, Campas M (1996) The effect of small-diameter H-graft portocaval shunts on portal blood flow. Am J Surg 171:154–156PubMedCrossRef
35.
Zurück zum Zitat Takada Y, Ueda M, Ishikawa Y, et al. (2004) End-to-side portocaval shunting for a small-for-size graft in living donor liver transplantation. Liver Transpl 10:807–810PubMedCrossRef Takada Y, Ueda M, Ishikawa Y, et al. (2004) End-to-side portocaval shunting for a small-for-size graft in living donor liver transplantation. Liver Transpl 10:807–810PubMedCrossRef
36.
Zurück zum Zitat Reichert PR, Pires JR, Sallet CA, et al. (2004) Liver transplantation in pigs with small-for-size grafts: effect of portocaval shunt. Transplant Proc 36:1007–1008PubMedCrossRef Reichert PR, Pires JR, Sallet CA, et al. (2004) Liver transplantation in pigs with small-for-size grafts: effect of portocaval shunt. Transplant Proc 36:1007–1008PubMedCrossRef
37.
Zurück zum Zitat Sato Y, Yamamoto S, Takeishi T, et al. (2006) Management of major portosystemic shunting in small-for-size adult living related donor liver transplantation with a left-sided graft liver. Surg Today 36:354–360PubMedCrossRef Sato Y, Yamamoto S, Takeishi T, et al. (2006) Management of major portosystemic shunting in small-for-size adult living related donor liver transplantation with a left-sided graft liver. Surg Today 36:354–360PubMedCrossRef
38.
Zurück zum Zitat Sato Y, Yamamoto S, Takeishi T, et al. (2004) Inferior mesenteric venous left renal vein shunting for decompression of excessive portal hypertension in adult living related liver transplantation. Transplant Proc 36:2234–2236PubMedCrossRef Sato Y, Yamamoto S, Takeishi T, et al. (2004) Inferior mesenteric venous left renal vein shunting for decompression of excessive portal hypertension in adult living related liver transplantation. Transplant Proc 36:2234–2236PubMedCrossRef
Metadaten
Titel
Beneficial Effect of Partial Portal Decompression Using the Inferior Mesenteric Vein for Intractable Gastroesophageal Variceal Bleeding in Patients With Liver Cirrhosis
verfasst von
Satoshi Yamamoto
Yoshinobu Sato
Hideki Nakatsuka
Hiroshi Oya
Takashi Kobayashi
Katsuyoshi Hatakeyama
Publikationsdatum
01.06.2007
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 6/2007
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-007-9005-7

Weitere Artikel der Ausgabe 6/2007

World Journal of Surgery 6/2007 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.